Synthesis, in vitro and in silico anticancer evaluation of novel pyridin-2-yl estra-1,3,5(10)-triene derivatives
Future Medicinal Chemistry · 2024
DOI: 10.4155/fmc-2024-0039 ↗Kurz gefasst
Fachartikel in der Zeitschrift Future Medicinal Chemistry, 2024. Verfasst von Milica Z Stevanović und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Biochemistry & Environmental Protection, University of Novi Sad, Faculty of Sciences, Trg Dositeja Obradovića 3, 21000 Novi …. Hauptthemen laut MEDLINE: Antineoplastic Agents, Molecular Docking Simulation, Cell Proliferation, Drug Screening Assays, Antitumor. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: the Ministry of Science, Technological Development and Innovation of the Republic of Serbia, Provincial Secretariat for Higher Education and Scientific Research of the Autonomous Province of Vojvodina.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, Biochemistry & Environmental Protection, University of Novi Sad, Faculty of Sciences, Trg Dositeja Obradovića 3, 21000 Novi Sad, Serbia.
- Department of Biology & Ecology, University of Novi Sad, Faculty of Sciences, Trg Dositeja Obradovića 2, 21000 Novi Sad, Serbia.
- Oncology Institute of Vojvodina, Faculty of Medicine, University of Novi Sad, Put Dr Goldmana 4, 21204 Sremska Kamenica, Serbia.
ORCID-Profile: Milica Z Stevanović, Sofija S Bekić, Edward T Petri, Andjelka S Ćelić, Dimitar S Jakimov, Marija N Sakač, Ivana Z Kuzminac
Förderung
- the Ministry of Science, Technological Development and Innovation of the Republic of Serbia
- Provincial Secretariat for Higher Education and Scientific Research of the Autonomous Province of Vojvodina
Zitieren
APA
Stevanović, M. Z., Bekić, S. S., Petri, E. T., Ćelić, A. S., Jakimov, D. S., Sakač, M. N., & Kuzminac, I. Z. (2024). Synthesis, in vitro and in silico anticancer evaluation of novel pyridin-2-yl estra-1,3,5(10)-triene derivatives. Future Medicinal Chemistry. https://doi.org/10.4155/fmc-2024-0039
Vancouver
Stevanović MZ, Bekić SS, Petri ET, Ćelić AS, Jakimov DS, Sakač MN, et al. Synthesis, in vitro and in silico anticancer evaluation of novel pyridin-2-yl estra-1,3,5(10)-triene derivatives. Future Medicinal Chemistry. 2024. doi:10.4155/fmc-2024-0039
BibTeX
@article{Stevanovi2024,
author = {Stevanović, Milica Z and Bekić, Sofija S and Petri, Edward T and Ćelić, Andjelka S and Jakimov, Dimitar S and Sakač, Marija N and Kuzminac, Ivana Z},
title = {Synthesis, in vitro and in silico anticancer evaluation of novel pyridin-2-yl estra-1,3,5(10)-triene derivatives},
journal = {Future Medicinal Chemistry},
year = {2024},
doi = {10.4155/fmc-2024-0039}
}
EUVIMED